Molecular data is typically collected through various high-throughput technologies such as next-generation sequencing (NGS), microarrays, and mass spectrometry. These technologies allow for comprehensive analysis of genetic mutations, gene expression, and protein levels in cancer cells. Data can also be obtained from biopsies and liquid biopsies, providing insights into the molecular makeup of tumors and circulating tumor DNA (ctDNA) in the bloodstream.
